$INCY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INCYTE CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INCYTE CORP. Get notifications about new insider transactions in INCYTE CORP for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 21 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 60.85 | 97,484 | 5,931,960 | 19,494,052 | 19.4 M to 19.5 M (+0.50 %) |
Mar 17 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 60.85 | 10,616 | 645,990 | 3,330,284 | 3.3 M to 3.3 M (+0.32 %) |
Mar 17 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 3.86 | 20,000 | 77,200 | 533,020 | 513 K to 533 K (+3.90 %) |
Mar 17 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 3.86 | 20,000 | 77,200 | 19,396,568 | 19.4 M to 19.4 M (+0.10 %) |
Mar 17 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 3.86 | 20,000 | 77,200 | 3,319,668 | 3.3 M to 3.3 M (+0.61 %) |
Mar 17 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 65.29 | 1,182 | 77,176 | 19,376,568 | 19.4 M to 19.4 M (+0.01 %) |
Mar 17 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 65.29 | 129 | 8,423 | 3,299,668 | 3.3 M to 3.3 M (0.00 %) |
Mar 17 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 65.80 | 179,176 | 11,789,387 | 19,375,386 | 19.2 M to 19.4 M (+0.93 %) |
Mar 17 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 65.80 | 19,513 | 1,283,912 | 3,299,539 | 3.3 M to 3.3 M (+0.59 %) |
Mar 17 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 67.15 | 180,358 | 12,110,607 | 19,196,210 | 19 M to 19.2 M (+0.95 %) |
Mar 17 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 67.15 | 19,642 | 1,318,913 | 3,280,026 | 3.3 M to 3.3 M (+0.60 %) |
Feb 29 2016 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Option Exercise | M | 18.32 | 6,566 | 120,289 | 0 | |
Feb 29 2016 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Buy | M | 18.32 | 6,566 | 120,289 | 30,547 | 24 K to 30.5 K (+27.38 %) |
Feb 26 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 74.00 | 6,022 | 445,628 | 19,015,852 | 19 M to 19 M (+0.03 %) |
Feb 26 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 74.00 | 678 | 50,172 | 3,260,384 | 3.3 M to 3.3 M (+0.02 %) |
Feb 26 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 69.70 | 20,492 | 1,428,282 | 19,009,830 | 19 M to 19 M (+0.11 %) |
Feb 26 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 69.70 | 2,308 | 160,866 | 3,259,706 | 3.3 M to 3.3 M (+0.07 %) |
Feb 26 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 70.51 | 23,157 | 1,632,684 | 18,989,338 | 19 M to 19 M (+0.12 %) |
Feb 26 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 70.51 | 2,608 | 183,877 | 3,257,398 | 3.3 M to 3.3 M (+0.08 %) |
Feb 26 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 71.96 | 8,111 | 583,702 | 18,966,181 | 19 M to 19 M (+0.04 %) |
Feb 26 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 71.96 | 914 | 65,775 | 3,254,790 | 3.3 M to 3.3 M (+0.03 %) |
Feb 18 2016 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Option Exercise | M | 18.32 | 5,377 | 98,507 | 0 | |
Feb 18 2016 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Buy | M | 18.32 | 5,377 | 98,507 | 71,046 | 65.7 K to 71 K (+8.19 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 69.45 | 15,187 | 1,054,742 | 18,958,070 | 18.9 M to 19 M (+0.08 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 69.45 | 1,651 | 114,662 | 3,253,876 | 3.3 M to 3.3 M (+0.05 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 70.86 | 8,250 | 584,597 | 18,942,883 | 18.9 M to 18.9 M (+0.04 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 70.86 | 897 | 63,562 | 3,252,225 | 3.3 M to 3.3 M (+0.03 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 69.54 | 67,373 | 4,684,923 | 18,934,633 | 18.9 M to 18.9 M (+0.36 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 69.54 | 7,326 | 509,429 | 3,251,328 | 3.2 M to 3.3 M (+0.23 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 70.21 | 124,057 | 8,710,228 | 18,867,260 | 18.7 M to 18.9 M (+0.66 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 70.21 | 13,490 | 947,153 | 3,244,002 | 3.2 M to 3.2 M (+0.42 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 71.10 | 397,079 | 28,233,945 | 18,743,203 | 18.3 M to 18.7 M (+2.16 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 71.10 | 43,178 | 3,070,133 | 3,230,512 | 3.2 M to 3.2 M (+1.35 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 67.94 | 149,927 | 10,186,595 | 18,346,124 | 18.2 M to 18.3 M (+0.82 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 67.94 | 16,450 | 1,117,674 | 3,187,334 | 3.2 M to 3.2 M (+0.52 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 63.98 | 38,117 | 2,438,547 | 18,196,197 | 18.2 M to 18.2 M (+0.21 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 63.98 | 4,183 | 267,609 | 3,170,884 | 3.2 M to 3.2 M (+0.13 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 64.87 | 168,055 | 10,902,350 | 18,158,080 | 18 M to 18.2 M (+0.93 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 64.87 | 18,441 | 1,196,336 | 3,166,701 | 3.1 M to 3.2 M (+0.59 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 65.80 | 541,340 | 35,621,958 | 17,990,025 | 17.4 M to 18 M (+3.10 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 65.80 | 59,401 | 3,908,782 | 3,148,260 | 3.1 M to 3.1 M (+1.92 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 66.68 | 49,021 | 3,268,823 | 17,448,685 | 17.4 M to 17.4 M (+0.28 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 66.68 | 5,379 | 358,683 | 3,088,859 | 3.1 M to 3.1 M (+0.17 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 67.68 | 72,894 | 4,933,706 | 17,399,664 | 17.3 M to 17.4 M (+0.42 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 67.68 | 7,999 | 541,399 | 3,083,480 | 3.1 M to 3.1 M (+0.26 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 60.85 | 6,939 | 422,220 | 17,326,770 | 17.3 M to 17.3 M (+0.04 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 60.85 | 761 | 46,305 | 3,075,481 | 3.1 M to 3.1 M (+0.02 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 61.73 | 57,865 | 3,572,047 | 17,319,831 | 17.3 M to 17.3 M (+0.34 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 61.73 | 6,349 | 391,928 | 3,074,720 | 3.1 M to 3.1 M (+0.21 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 58.13 | 136,793 | 7,952,133 | 17,261,966 | 17.1 M to 17.3 M (+0.80 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 58.13 | 15,010 | 872,570 | 3,068,371 | 3.1 M to 3.1 M (+0.49 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 59.01 | 114,908 | 6,780,526 | 17,125,173 | 17 M to 17.1 M (+0.68 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 59.01 | 12,609 | 744,036 | 3,053,361 | 3 M to 3.1 M (+0.41 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 60.40 | 65,309 | 3,944,513 | 17,010,265 | 16.9 M to 17 M (+0.39 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 60.40 | 7,166 | 432,810 | 3,040,752 | 3 M to 3 M (+0.24 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 61.40 | 113,546 | 6,971,475 | 16,944,956 | 16.8 M to 16.9 M (+0.67 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 61.40 | 12,459 | 764,955 | 3,033,586 | 3 M to 3 M (+0.41 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 62.56 | 289,755 | 18,126,986 | 16,831,410 | 16.5 M to 16.8 M (+1.75 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 62.56 | 31,795 | 1,989,086 | 3,021,127 | 3 M to 3 M (+1.06 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 63.37 | 176,647 | 11,194,368 | 16,541,655 | 16.4 M to 16.5 M (+1.08 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 63.37 | 19,383 | 1,228,328 | 2,989,332 | 3 M to 3 M (+0.65 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 64.46 | 235,734 | 15,195,814 | 16,365,008 | 16.1 M to 16.4 M (+1.46 %) |
Feb 16 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | P | 64.46 | 25,869 | 1,667,560 | 2,969,949 | 2.9 M to 3 M (+0.88 %) |
Jan 20 2016 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | M | 3.11 | 13,531 | 42,081 | 0 | |
Jan 20 2016 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Sell | S | 76.96 | 13,531 | 1,041,346 | 23,693 | 37.2 K to 23.7 K (-36.35 %) |
Jan 20 2016 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Buy | M | 3.11 | 13,531 | 42,081 | 37,224 | 23.7 K to 37.2 K (+57.11 %) |
Jan 20 2016 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 18.32 | 2,509 | 45,965 | 2,223 | |
Jan 20 2016 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 18.32 | 2,509 | 45,965 | 8,829 | 6.3 K to 8.8 K (+39.70 %) |
Jan 08 2016 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Option Exercise | A | 95.76 | 1,044 | 99,973 | 1,044 | |
Jan 08 2016 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Option Exercise | A | 95.76 | 12,587 | 1,205,331 | 12,587 | |
Jan 08 2016 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Option Exercise | A | 95.76 | 586 | 56,115 | 586 | |
Jan 08 2016 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Option Exercise | A | 95.76 | 18,198 | 1,742,640 | 18,198 | |
Jan 08 2016 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Grant | A | 0.00 | 2,610 | 0 | 23,981 | 21.4 K to 24 K (+12.21 %) |
Jan 08 2016 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Option Exercise | A | 95.76 | 869 | 83,215 | 869 | |
Jan 08 2016 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Option Exercise | A | 95.76 | 5,047 | 483,301 | 5,047 | |
Jan 08 2016 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Grant | A | 0.00 | 822 | 0 | 8,418 | 7.6 K to 8.4 K (+10.82 %) |
Jan 08 2016 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 95.76 | 1,044 | 99,973 | 1,044 | |
Jan 08 2016 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 95.76 | 2,995 | 286,801 | 2,995 | |
Jan 08 2016 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 95.76 | 1,108 | 106,102 | 1,108 | |
Jan 08 2016 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 95.76 | 17,676 | 1,692,654 | 17,676 | |
Jan 08 2016 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Grant | A | 0.00 | 2,610 | 0 | 23,693 | 21.1 K to 23.7 K (+12.38 %) |
Jan 08 2016 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | A | 95.76 | 1,044 | 99,973 | 1,044 | |
Jan 08 2016 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | A | 95.76 | 2,995 | 286,801 | 2,995 | |
Jan 08 2016 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | A | 95.76 | 1,108 | 106,102 | 1,108 | |
Jan 08 2016 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | A | 95.76 | 17,676 | 1,692,654 | 17,676 | |
Jan 08 2016 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Grant | A | 0.00 | 2,610 | 0 | 6,320 | 3.7 K to 6.3 K (+70.35 %) |
Jan 08 2016 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 3,937 | 72,126 | 2,876 | |
Jan 08 2016 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 101.86 | 3,937 | 401,023 | 16,926 | 20.9 K to 16.9 K (-18.87 %) |
Jan 08 2016 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 3,937 | 72,126 | 20,863 | 16.9 K to 20.9 K (+23.26 %) |
Jan 08 2016 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Option Exercise | A | 95.76 | 1,044 | 99,973 | 1,044 | |
Jan 08 2016 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Option Exercise | A | 95.76 | 21,170 | 2,027,239 | 21,170 | |
Jan 08 2016 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Option Exercise | A | 95.76 | 586 | 56,115 | 586 | |
Jan 08 2016 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Option Exercise | A | 95.76 | 18,198 | 1,742,640 | 18,198 | |
Jan 08 2016 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Grant | A | 0.00 | 2,610 | 0 | 65,669 | 63.1 K to 65.7 K (+4.14 %) |
Jan 08 2016 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Option Exercise | A | 95.76 | 1,044 | 99,973 | 1,044 | |
Jan 08 2016 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Option Exercise | A | 95.76 | 19,151 | 1,833,900 | 19,151 | |
Jan 08 2016 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Option Exercise | A | 95.76 | 1,044 | 99,973 | 1,044 | |
Jan 08 2016 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Option Exercise | A | 95.76 | 74,094 | 7,095,241 | 74,094 | |
Jan 08 2016 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Grant | A | 0.00 | 10,442 | 0 | 360,203 | 349.8 K to 360.2 K (+2.99 %) |
Jan 08 2016 | INCY | INCYTE CORP | GRYSKA DAVID W | Executive Vice Pres ... | Option Exercise | A | 95.76 | 1,044 | 99,973 | 1,044 | |
Jan 08 2016 | INCY | INCYTE CORP | GRYSKA DAVID W | Executive Vice Pres ... | Option Exercise | A | 95.76 | 2,995 | 286,801 | 2,995 | |
Jan 08 2016 | INCY | INCYTE CORP | GRYSKA DAVID W | Executive Vice Pres ... | Option Exercise | A | 95.76 | 1,108 | 106,102 | 1,108 | |
Jan 08 2016 | INCY | INCYTE CORP | GRYSKA DAVID W | Executive Vice Pres ... | Option Exercise | A | 95.76 | 17,676 | 1,692,654 | 17,676 | |
Jan 08 2016 | INCY | INCYTE CORP | GRYSKA DAVID W | Executive Vice Pres ... | Grant | A | 0.00 | 2,610 | 0 | 13,460 | 10.9 K to 13.5 K (+24.06 %) |
Jan 08 2016 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Option Exercise | A | 95.76 | 1,044 | 99,973 | 1,044 | |
Jan 08 2016 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Option Exercise | A | 95.76 | 2,995 | 286,801 | 2,995 | |
Jan 08 2016 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Option Exercise | A | 95.76 | 1,108 | 106,102 | 1,108 | |
Jan 08 2016 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Option Exercise | A | 95.76 | 17,676 | 1,692,654 | 17,676 | |
Jan 08 2016 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Grant | A | 0.00 | 2,610 | 0 | 5,632 | 3 K to 5.6 K (+86.37 %) |
Jan 05 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Grant | A | 108.45 | 175 | 18,979 | 513,020 | 512.8 K to 513 K (+0.03 %) |
Jan 05 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Grant | A | 108.45 | 175 | 18,979 | 16,129,274 | 16.1 M to 16.1 M (0.00 %) |
Jan 05 2016 | INCY | INCYTE CORP | BAKER JULIAN | Director | Grant | A | 108.45 | 175 | 18,979 | 2,944,080 | 2.9 M to 2.9 M (+0.01 %) |
Dec 31 2015 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Payment of Exercise | F | 109.11 | 32,297 | 3,523,926 | 349,761 | 382.1 K to 349.8 K (-8.45 %) |
Dec 31 2015 | INCY | INCYTE CORP | BROOKE PAUL A | Director | Grant | A | 108.45 | 218 | 23,642 | 175,466 | 175.2 K to 175.5 K (+0.12 %) |
Dec 31 2015 | INCY | INCYTE CORP | DIXON WENDY L | Director | Grant | A | 108.45 | 149 | 16,159 | 7,951 | 7.8 K to 8 K (+1.91 %) |
Dec 31 2015 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 108.45 | 133 | 14,424 | 391 | 258 to 391 (+51.55 %) |
Dec 14 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 18.32 | 1,936 | 35,468 | 0 | |
Dec 14 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Sell | S | 107.96 | 1,936 | 209,011 | 3,710 | 5.6 K to 3.7 K (-34.29 %) |
Dec 14 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 18.32 | 1,936 | 35,468 | 5,646 | 3.7 K to 5.6 K (+52.18 %) |
Dec 09 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 3,937 | 72,126 | 6,813 | |
Dec 09 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 106.18 | 3,937 | 418,031 | 16,926 | 20.9 K to 16.9 K (-18.87 %) |
Dec 09 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 3,937 | 72,126 | 20,863 | 16.9 K to 20.9 K (+23.26 %) |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | M | 17.79 | 125,000 | 2,223,750 | 0 | |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | M | 17.79 | 94,379 | 1,679,002 | 125,000 | |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | M | 17.79 | 5,621 | 99,998 | 0 | |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 115.12 | 38,868 | 4,474,484 | 297,518 | 336.4 K to 297.5 K (-11.55 %) |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 115.42 | 86,132 | 9,941,355 | 336,386 | 422.5 K to 336.4 K (-20.39 %) |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | M | 17.79 | 125,000 | 2,223,750 | 422,518 | 297.5 K to 422.5 K (+42.01 %) |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 111.37 | 50,000 | 5,568,500 | 297,518 | 347.5 K to 297.5 K (-14.39 %) |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 112.53 | 42,948 | 4,832,938 | 347,518 | 390.5 K to 347.5 K (-11.00 %) |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 112.71 | 7,052 | 794,831 | 390,466 | 397.5 K to 390.5 K (-1.77 %) |
Nov 19 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | M | 17.79 | 100,000 | 1,779,000 | 397,518 | 297.5 K to 397.5 K (+33.61 %) |
Nov 12 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 18.32 | 286 | 5,240 | 4,732 | |
Nov 12 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 18.32 | 1,936 | 35,468 | 1,936 | |
Nov 12 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Sell | S | 104.86 | 2,222 | 232,999 | 3,710 | 5.9 K to 3.7 K (-37.46 %) |
Nov 12 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 18.32 | 286 | 5,240 | 5,932 | 5.6 K to 5.9 K (+5.07 %) |
Nov 12 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 18.32 | 1,936 | 35,468 | 5,646 | 3.7 K to 5.6 K (+52.18 %) |
Nov 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 3,936 | 72,108 | 10,750 | |
Nov 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 116.51 | 3,936 | 458,583 | 16,926 | 20.9 K to 16.9 K (-18.87 %) |
Nov 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 3,936 | 72,108 | 20,862 | 16.9 K to 20.9 K (+23.25 %) |
Nov 05 2015 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Option Exercise | M | 17.79 | 5,000 | 88,950 | 25,354 | |
Nov 05 2015 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Sell | S | 124.75 | 5,000 | 623,750 | 21,371 | 26.4 K to 21.4 K (-18.96 %) |
Nov 05 2015 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Buy | M | 17.79 | 5,000 | 88,950 | 26,371 | 21.4 K to 26.4 K (+23.40 %) |
Nov 05 2015 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Sell | S | 124.95 | 786 | 98,211 | 21,371 | 22.2 K to 21.4 K (-3.55 %) |
Oct 15 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 18.32 | 286 | 5,240 | 5,018 | |
Oct 15 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 18.32 | 1,936 | 35,468 | 3,872 | |
Oct 15 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Sell | S | 101.49 | 2,222 | 225,511 | 3,355 | 5.6 K to 3.4 K (-39.84 %) |
Oct 15 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 18.32 | 286 | 5,240 | 5,577 | 5.3 K to 5.6 K (+5.41 %) |
Oct 15 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 18.32 | 1,936 | 35,468 | 5,291 | 3.4 K to 5.3 K (+57.70 %) |
Oct 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 3,937 | 72,126 | 14,686 |